HPM Partners »

Eledon Pharmaceuticals shares owned by HPM Partners

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by HPM Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $105k 27k 3.94

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
Procter & Gamble Company (PG)
Eli Lilly & Co. (LLY)

View all positions for HPM Partners

Top funds holding Eledon Pharmaceuticals

BVF
BlackRock
Defilade Capital Management
Vanguard Capital Management
Goldman Sachs Group
Ensign Peak Advisors
Geode Capital Management
Catalio Capital Management
Zimmer Partners
Sphera Funds Management
State Street Corporation
AWM Investment Company
UBS Group
Kingdon Capital Management
Millennium Management

View all funds holding Eledon Pharmaceuticals